Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Bleich who wrote (663)	10/16/1997 3:52:00 PM
From: Henry Volquardsen	of 1115

David, welcome aboard. The melanoma vaccine is not the major play on Lidak at the moment but is one of several intersting kickers in the background. The main play on this stock at the moment is Lidakol (n-docassonal). This is an anti-viral that is currently being tested as a treatment for oral herpes. It is also has potential application for genital herpes, shingles and a few others. They have just completed phase III trials and were pleased. We are awaiting publication of specific data within the next few weeks. The NDA is already under preperation. They have marketing arrangements with Bristol Meyers for the US and a Japanese drug firm (Yamanouchi?). I forget what the burn rate is but recall that they have money for two (?) more years and personally believe Lidakol will recieve its NDA before then. Dr. Katz is the guiding light of Lidak and as I recall he has extensive experience but am not certain. Someone else maybe able to fill in details. Luis? John? what did I miss?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next